UBS Group’s Verona Pharma VRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$112M Buy
1,186,181
+923,327
+351% +$87.3M 0.02% 717
2025
Q1
$16.7M Sell
262,854
-110,551
-30% -$7.02M ﹤0.01% 1944
2024
Q4
$17.3M Buy
373,405
+238,837
+177% +$11.1M ﹤0.01% 1878
2024
Q3
$3.87M Buy
134,568
+31,689
+31% +$912K ﹤0.01% 2498
2024
Q2
$1.49M Buy
102,879
+101,044
+5,506% +$1.46M ﹤0.01% 3083
2024
Q1
$29.5K Sell
1,835
-179
-9% -$2.88K ﹤0.01% 5579
2023
Q4
$40K Sell
2,014
-1,323
-40% -$26.3K ﹤0.01% 5468
2023
Q3
$54.4K Buy
3,337
+332
+11% +$5.41K ﹤0.01% 5112
2023
Q2
$63.5K Sell
3,005
-2,427
-45% -$51.3K ﹤0.01% 5277
2023
Q1
$109K Buy
5,432
+1,263
+30% +$25.4K ﹤0.01% 4788
2022
Q4
$109K Buy
4,169
+3,391
+436% +$88.6K ﹤0.01% 4908
2022
Q3
$8K Buy
+778
New +$8K ﹤0.01% 7651
2022
Q2
Sell
-655
Closed -$3K 9784
2022
Q1
$3K Buy
+655
New +$3K ﹤0.01% 8433
2021
Q4
Sell
-879
Closed -$5K 9428
2021
Q3
$5K Buy
+879
New +$5K ﹤0.01% 7412
2021
Q2
Sell
-1,407
Closed -$12K 8617
2021
Q1
$12K Sell
1,407
-316
-18% -$2.7K ﹤0.01% 6787
2020
Q4
$12K Buy
1,723
+327
+23% +$2.28K ﹤0.01% 6339
2020
Q3
$9K Buy
+1,396
New +$9K ﹤0.01% 6075
2020
Q2
Sell
-4,000
Closed -$16K 7341
2020
Q1
$16K Sell
4,000
-6,055
-60% -$24.2K ﹤0.01% 5740
2019
Q4
$58K Buy
10,055
+8,940
+802% +$51.6K ﹤0.01% 5223
2019
Q3
$5K Sell
1,115
-272
-20% -$1.22K ﹤0.01% 6521
2019
Q2
$7K Buy
+1,387
New +$7K ﹤0.01% 6377
2019
Q1
Sell
-138
Closed -$1K 7143
2018
Q4
$1K Buy
+138
New +$1K ﹤0.01% 6984
2018
Q2
Sell
-703
Closed -$14K 7173
2018
Q1
$14K Buy
703
+702
+70,200% +$14K ﹤0.01% 5788
2017
Q4
$0 Buy
+1
New ﹤0.01% 6993